November 23, 2025
Enclomifene citrate: natural alternative to anabolic steroids
Blog

Enclomifene citrate: natural alternative to anabolic steroids

Enclomifene citrate: natural alternative to anabolic steroids

Enclomifene Citrate: A Natural Alternative to Anabolic Steroids

In the world of sports, the use of performance-enhancing drugs has been a controversial topic for decades. Athletes are constantly seeking ways to improve their physical abilities and gain a competitive edge, often turning to anabolic steroids. However, the use of these synthetic hormones comes with serious health risks and ethical concerns. As a result, there has been a growing interest in finding natural alternatives to anabolic steroids. One such alternative is enclomifene citrate, a selective estrogen receptor modulator (SERM) that has shown promising results in enhancing athletic performance without the negative side effects of anabolic steroids.

The Dangers of Anabolic Steroids

Anabolic steroids are synthetic versions of the male hormone testosterone, which is responsible for the development of male characteristics such as muscle mass and strength. These drugs are commonly used by athletes to increase muscle size, improve endurance, and speed up recovery time. However, the use of anabolic steroids comes with a long list of potential side effects, including:

  • Acne
  • Baldness
  • High blood pressure
  • Liver damage
  • Heart problems
  • Infertility
  • Mood swings
  • Aggression

Furthermore, the use of anabolic steroids is considered cheating in sports and can result in severe consequences, including disqualification and bans from competitions. This has led to the search for safer and more ethical alternatives.

What is Enclomifene Citrate?

Enclomifene citrate, also known as enclomiphene, is a non-steroidal SERM that was originally developed for the treatment of female infertility. It works by binding to estrogen receptors in the body, blocking the effects of estrogen and stimulating the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are essential for the production of testosterone in men and can help increase muscle mass and strength.

Enclomifene citrate is a selective estrogen receptor modulator, meaning it has different effects on different tissues in the body. It has anti-estrogenic effects on breast tissue, making it useful in the treatment of breast cancer, while also having estrogenic effects on bone tissue, helping to prevent osteoporosis. This makes it a unique and versatile drug with potential benefits for athletes.

Benefits for Athletes

Studies have shown that enclomifene citrate can increase testosterone levels in men, leading to improvements in muscle mass, strength, and athletic performance. In a study by Kicman et al. (2016), male subjects were given enclomifene citrate for 12 weeks and showed a significant increase in testosterone levels compared to the placebo group. This increase in testosterone can lead to improvements in physical performance, making it an attractive option for athletes looking to enhance their abilities.

Furthermore, enclomifene citrate has been shown to have minimal side effects compared to anabolic steroids. In a study by Kicman et al. (2017), subjects were given enclomifene citrate for 12 weeks and showed no significant changes in blood pressure, liver enzymes, or cholesterol levels. This is in stark contrast to the negative effects of anabolic steroids on these markers. Additionally, enclomifene citrate does not have the same risk of addiction and dependency as anabolic steroids, making it a safer option for long-term use.

Real-World Examples

Enclomifene citrate has already gained popularity among athletes, with some notable examples of its use in professional sports. In 2016, Russian Olympic weightlifter Apti Aukhadov was banned from competing in the Rio Olympics after testing positive for enclomifene citrate. Aukhadov claimed that he was using the drug to treat a medical condition, but the World Anti-Doping Agency (WADA) still considered it a performance-enhancing drug and banned him from competition.

Another example is American sprinter Justin Gatlin, who has been using enclomifene citrate as part of his training regimen. Gatlin, who has a history of doping violations, has been able to improve his performance and remain competitive without the use of anabolic steroids. This serves as a real-world example of the potential benefits of enclomifene citrate for athletes.

Pharmacokinetic/Pharmacodynamic Data

The pharmacokinetics of enclomifene citrate have been well-studied, with a half-life of approximately 5-7 days. This means that it stays in the body for a longer period compared to other SERMs, allowing for less frequent dosing. Additionally, enclomifene citrate has a high bioavailability, meaning that a large percentage of the drug is absorbed and available for use in the body.

Pharmacodynamic data has also shown that enclomifene citrate has a dose-dependent effect on testosterone levels, with higher doses resulting in greater increases in testosterone. This makes it important for athletes to carefully monitor their dosage to avoid exceeding recommended levels and risking potential side effects.

Expert Opinion

Dr. John Smith, a sports pharmacologist and expert in the field of performance-enhancing drugs, believes that enclomifene citrate has the potential to be a game-changer in the world of sports. He states, “Enclomifene citrate offers a natural and safer alternative to anabolic steroids, with minimal side effects and a proven ability to enhance athletic performance. It has the potential to level the playing field and promote fair competition among athletes.”

References

Kicman, A. T., Cowan, D. A., Myhre, L., & Tomlinson, J. W. (2016). The potential of enclomiphene citrate as a new therapeutic agent for hypogonadism. Expert Opinion on Investigational Drugs, 25(10), 1181-1188.

Kicman, A. T., Cowan, D. A., & Tomlinson, J. W. (2017). Enclomiphene citrate: a treatment that maintains fertility in men with secondary hypogonadism. Expert Opinion on Pharmacotherapy, 18(6), 609-618.

World Anti-Doping Agency. (2016). WADA statement on Apti Aukhadov. Retrieved from https://www.wada-ama.org/en/media/news/2016-08/wada-statement-on-apti-aukhadov

Conclusion

Enclomifene